L41 - Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results
| Autor: | Soldà, C., Bardini, R., Sperti, C., Da Dalt, G., Gion, M., Fiduccia, P., Ursini, F., Aliberti, C., Pastorelli, D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2015 26 Supplement 6:vi102-vi102 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|